Sarah Cannon Research Institute

Sarasota, Florida 34232

1 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor With Evidence of Germline or Somatic BRCA, Advanced Solid Tumors or Lymphomas, Carcinoma, Non-small-cell Lung, Colorectal Cancer, Esophageal Neoplasms, Fallopian Tube Cancer, Gastric Cancer, Locally Advanced or Metastatic Solid Tumors, Metastatic Pancreatic Cancer, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer

Studies at this site

• A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors — Recruiting now
• A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) — Completed
• A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors — Completed
• A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas — Completed